Thrombophilic mutations are a main risk factor for placental abruption

Haematologica

Volumn 88, Issue 7, 2003, Pages 785-788

  Facchinetti, Fabio ^a,d   Marozio, Luca ^b   Grandone, Elvira ^c   Pizzi, Cristina ^a   Volpe, Annibale ^a   Benedetto, Chiara ^b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^d Dipartimento Materno Infantile   (Italy)

Author keywords

Abruptio placentae; Factor II mutation A20210; Factor V Leiden

Indexed keywords

BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; ARTICLE; CAUCASIAN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE MUTATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HYPERTENSION; ITALY; MULTICENTER STUDY; PARITY; PREECLAMPSIA; PREGNANCY; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SOLUTIO PLACENTAE; THROMBOPHILIA;

ABRUPTIO PLACENTAE; ADOLESCENT; ADULT; CASE-CONTROL STUDIES; FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; PREGNANCY; PROTHROMBIN; RISK FACTORS; THROMBOPHILIA;

EID: 0037483677     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Cunningham FG, Gant NF, Leveno KJ, Gilstrap III LC, Hauth JC, Wenstrom KD. In: William's Obstetrics. 21th ed. McGraw-Hill. p. 621-30.
2. Gherman RB, Goodwin MT. Obstetric implications of activated protein C resistance and Factor V Leiden mutation. Obstet Gynecol Surv 2000;55:117-22.
3. Bloomenthal D, Von Dadelszen P, Liston R, Magee L, Tsang P. The effect of factor V Leiden carriage on maternal and fetal health. J Can Med Ass 2002;167:48-54.
4. Martinelli P, Grandone E, Colaizzo D, Paladini D, Scianname N, Margaglione M. Familial thrombophilia and the occurrence of fetal growth restriction. Haematologica 2001; 86:428-31.
5. Many A, Schreiber L, Rosner S, Lessing JB, Eldor A, Kupferminc MJ. Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia. Obstet Gyneacol 2001;98:1041-4.
6. Dizon-Towson DS, Meline L, Nelson LM, Varner M, Ward K. Fetal carriers of factor V Leiden mutation are prone to miscarriage and placental infarction. Am J Obstet Gynecol 1997; 177:402-5.
7. Wiener-Megnagi Z, Ben-Shlomo I, Goldberg Y, Shalev E. Resistance to activated protein C and the Leiden mutation: high prevalence in patients with abruptio placentae. Am J Obstet Gynecol 1998;179:1565-7.
8. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999;340:9-13.
9. Kupferminc MJ, Peri H, Zwang E, Yaron Y, Wolman I, Eldor A. High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester loss. Acta Obstet Gynecol Scand 2000;79:963-7.
10. Grandone E, Margaglione M, Colaizzo D, D'Andrea G, Cappucci G, Brancaccia V, et al. Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations. Am J Obstet Gynecol 1998;179:1324-8.
11. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′ -untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-707.
12. Lindqvist PG, Svensson PJ, Marsal K, Grennert L, Luterkort M, Dahlback B. Activated protein C resistance (FV:Q506) and pregnancy. Thromb Haemost 1996;81:532-7.
13. Hira B, Pegoraro RJ, Rom L, Govender T, Moodley J. Polymorphisms in various coagulation genes in black south African women with placental abruption. Br J Obstet Gynecol 2002;109:574-5.
14. Alfiveric Z, Roberts D, Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? Obstet Gynecol 2002;101:6-14.
15. Benedetto C, Marozio L, Salton L, Maulà V, Chieppa G, Massobrio M. Factor V Leiden and factor II G 20210 A in preeclampsia and HELLP syndrome. Acta Obstet Gynecol Scand 2002;81:1095-100.